Saroja Pharma Industries India Limited is an India-based pharmaceutical and healthcare company. The Company is in Active Pharmaceuticals Ingredients (APIS), Specialty Chemicals, Intermediates for Pharma trading. It operates as a trader, exporter and supplier of Specialty Chemicals. It supplies products like Liquide Bromine used as an Agro Intermediate, Ethyl Acetate used as an API solvent as an agro intermediate, and other drugs that are used for human and veterinary medicines, and some of them are API solvents. It offers products in three categories, which include Chemical, Pharma Intermediary, and Veterinary Pharma API. Its Chemical products include Liquid Bromine, Ethyl Acetate, Thionyl Chloride, Para Nitro Phenol, Toluene N. G, and Benzyl Chloride. The Company’s Veterinary Pharma API products include Bromhexine HCL BP Grade, Triclabendazole, Fenbendazole BP Vet, Nitroxynil BP Vet, Oxfendazole BP Vet, Albendazole USP, Rafoxanide BP Vet, and Febantel EP, among others.As of 25 May 2026, SAROJA PHARMA INDUS IND L share price is ₹33.00. The stock opened at ₹33.00, compared to its previous close of ₹33.00. During today's trading session, SAROJA PHARMA INDUS IND L share price moved in the range of ₹33.00 to ₹33.00, with an average price of ₹33.00 for the day. Looking at its last 52-week, the stock has touched a low of ₹33.00 and a high of ₹33.00.
The market capitalization of SAROJA PHARMA INDUS IND L is ₹13 Crs, with a P/E ratio of 14.7 and a dividend yield of 0.00%.